Sort
261,768 grants matching “gene therapy”
Genetic susceptibility to unrelated donor stem cell transplant-related mortality
$1,214,404Theresa E Hahn · Roswell Park Cancer Institute Corp · R01 · FY2012 · HL
NF-kappaBeta Therapy for Duchenne Muscular Dystrophy
$1,214,077Denis C Guttridge · Ohio State University · U01 · FY2010 · NS
Transgenic Models for Prostate and Breast Cancer
$1,214,015Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Molecular Analysis Of Retroviral Genes And Their Products
$1,213,873Klaus Strebel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Whole genome sequencing consortium on Frontotemporal dementia with underlying TDP-43 pathology
$1,213,868Rosa Rademakers · Mayo Clinic Jacksonville · UH3 · FY2021 · NS
Whole genome sequencing consortium on Frontotemporal dementia with underlying TDP-43 pathology
$1,213,760Rosa Rademakers · Mayo Clinic Jacksonville · UH3 · FY2020 · NS
Effects of IL-6 blockade in treated HIV infection
$1,213,749Michael Marcel Lederman · Case Western Reserve University · U01 · FY2017 · AI
Molecular and Cellular Mechanisms of Experience-Dependent Cortical Processing
$1,213,622Kuan Wang · National Institute Of Mental Health · ZIA · FY2012 · MH
Activating Cell Death Pathways in Breast Cancer Cells
$1,213,551Stanley Lipkowitz · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA
Cellular In vivo Imaging
$1,213,366Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Impact of Stretching on Tumor growth and Metastasis
$1,213,161Lisbeth Berrueta · National Institute Of Dental & Craniofacial Research · ZIA · FY2024 · DE
Walking Forward - American Indian Participation in Cancer Clinical Trials
$1,213,118Daniel G Petereit · Rapid City Regional Hospital · U54 · FY2010 · CA
Effects of Medication for Opioid Use Disorder on Microglial Activation and Neurocognition in People Living with HIV
$1,213,037Shelli Farhadian · Yale University · R01 · FY2024 · DA
A phase I trial of AdKCNH2-G628S gene therapy for post-op atrial fibrillation
$1,212,885J Kevin Donahue · Univ Of Massachusetts Med Sch Worcester · R33 · FY2023 · HL
GENTICS OF USHER SYNDROME
$1,212,863Father Flanagan'S Boys'Home · P01 · FY2003 · DC
Preclinical drug development in pancreatic cancer
$1,212,844Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Biomarkers to Assess Selenium Chemoprevention for NSCLC
$1,212,592Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2009 · CA
Neuronal and Progenitor/Stem Cell Function During Salivary Gland Development
$1,212,589Matthew Hoffman · National Institute Of Dental & Craniofacial Research · ZIA · FY2018 · DE
Growth Factor/Extracellular Matrix Interactions During Branching Morphogenesis
$1,212,589Matthew Hoffman · National Institute Of Dental & Craniofacial Research · ZIA · FY2018 · DE
Nuclear Structure and Gene Expression
$1,212,440Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2010 · CA
Tyrosine kinase receptors (VEGFR and EGFR) regulate normal automaticity of heart pacemaker, the sinoatrial node.
$1,212,420Edward Lakatta · National Institute On Aging · ZIA · FY2025 · AG
PEDIATRIC AIDS CLINICAL TRIALS PROGRAM
$1,212,235Baylor College Of Medicine · U01 · FY2001 · AI
Mechanisms of Virus Entry into Cells and Antiviral Barriers Limiting Entry
$1,211,915Alex Compton · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Immune Reconstitution
$1,211,872Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response
$1,211,771Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA